Osstell and the ITI have signed a long-term partnership and collaboration agreement
Osstell, the global leader in implant stability measurement and osseointegration progress monitoring, and the International Team for Implantology (ITI), a leading academic organization dedicated to the promotion of evidence-based education and research in the field of implant dentistry, today announced that they have signed a long-term partnership and collaboration agreement.
Gothenburg, Sweden, May 30th: Osstell, the global leader in implant stability measurement and osseointegration progress monitoring, and the International Team for Implantology (ITI), a leading academic organization dedicated to the promotion of evidence-based education and research in the field of implant dentistry, today announced that they have signed a long-term partnership and collaboration agreement.
As one of the first sponsorship partners in a new initiative launched by the ITI to establish longer-term relationships with a small number of exclusively selected companies from the industry, Osstell will be working more closely with the ITI for an initial period of three years. The agreement encompasses primarily the contribution of educational material for the ITI community in its area of expertise, as well as participation in a number of ITI congresses and symposia. Osstell is now one of an appointed group of companies known as industry partners of the ITI.
“This global ITI initiative is based on a modular sponsorship concept that allow us to meet the individual needs of our partners,” said Charlotte Stilwell, ITI President. “It represents a mutually beneficial, longer-term commitment made by carefully selected companies that share similar educational and scientific, evidence-based principles as the ITI. We are very happy to welcome Osstell on board.”
Prof. Daniel Buser, ITI Past President, has been a clinical advisor for Osstell since its start. Prof. Buser highlighted the strong synergies that the partnership offers. “I have used the Osstell ISQ technique for roughly 20 years in daily practice. ISQ values are most important in my decision making, when to load an implant – and I am glad that Osstell and the ITI now can partner up so that more clinicians can learn about the value of Osstell’s ISQ Diagnostics.”
Dr Stephen Chen, ITI Past President, is a long time Osstell user and contributor to the successful ISQ symposium 2021. “A very similar philosophy drives the ITI and Osstell”, said Dr Stephen Chen. “When Osstell can work together with the ITI like this, it is the ideal way of spreading sound knowledge and clinical best practice.”
“Partnering together with the ITI is a natural extension of our commitment to clinical best practices and evidence. Clinicians use our diagnostic tools to ensure that they can deliver optimal implant treatments while ensuring predictability and patient satisfaction. We want to help them in any possible way and strongly believe that the ITI’s educational and evidence-based work is crucial for them” said Jonas Ehinger, Osstell CEO.
Osstell will provide the ITI community with exclusive educational activities such as online lectures with world-renowned experts within implant dentistry and invite the clinical community to join the first event, which is a CE webinar with Dr. Jeff Ganeles on June 1st, 6 PM (CET), who will discuss how smart case presentations lead to acceptance of complex and sophisticated treatment.
About the ITI
The International Team for Implantology (ITI) is an academic association that unites professionals around the world from every field of implant dentistry and related disciplines. The ITI’s purpose is to engage and inspire the global dental profession to strive for excellence in implant dentistry for the benefit of the patient. ITI Fellows and Members regularly share their knowledge and expertise from research and clinical practice at meetings, courses and congresses with the objective of continuously improving treatment methods and outcomes to the benefit of their patients.
In more than 40 years, the ITI has built a reputation for scientific rigor combined with concern for the welfare of patients. The organization focuses on the development of well-documented treatment guidelines backed by extensive clinical testing and the compilation of long-term results. The ITI funds research as well as Scholarships for young clinicians and offers a wealth of educational activities, courses and events both on- and offline to ensure a life-long learning journey for all professionals in implant dentistry. The organization also publishes reference books such as the ITI Treatment Guide series and operates the ITI Academy, a peer-reviewed, evidence-based e-learning platform with a unique user-centric approach. www.iti.org
Osstell is the global leader in implant stability measurement and osseointegration progress monitoring. Osstell was formed in 1999 to commercialize an invention using Resonance Frequency Analysis (RFA) to determine the clinical status of a dental implant. Osstell’s proprietary and patented technology helps dentists around the world provide their patients with optimal time to teeth, by measuring the stability of implants objectively and using the Osstell ISQ scale (Implant Stability Quotient). More than 1300 scientific publications confirm the benefits of the technology, its clinical value, and the use of the Osstell ISQ scale for dentists in their daily practice. Osstell is headquartered in Gothenburg, Sweden – the birthplace of dental implants. Since March 2018, Osstell is owned by W&H.
For further information please contact:
Jonas Ehinger, Osstell CEO